Kreos Capital, a provider of growth and venture debt financing to companies in the technology and healthcare industries, which was recently acquired by BlackRock, has held the final close of Kreos Capital VII (Kreos VII) above target at €1.2bn
The fund attracted support from over 30 institutional investors, including banks, sovereign wealth funds, public and private pension funds, insurance companies, fund of funds, foundations and family offices from over 13 countries globally, as well as global alternative asset consulting firms and investment advisory platforms.
The fund will continue Kreos’ investment strategy of providing loans to high-growth companies across EMEA, with a particular focus on the Technology and Healthcare sectors. Consistent with prior funds, Kreos VII will target investments in companies at every stage of their growth life cycle and can make investments from €2m up to €100m.
Kreos VII has actively commenced investing capital and to date has already completed 57 transactions in EMEA, committing a total of €1.1bn so far. With the benefit of being able to reinvest investment proceeds during the fund’s commitment period, Kreos VII is targeting total portfolio commitments of €2.4bn to €2.5bn in 90-100 companies.
